Erratum: Nurr1 represses tyrosine hydroxylase expression via SIRT1 in human neural stem cells (PLoS ONE (2013) 8:8 (e71469) 10.1371/journal.pone.0071469);Nurr1 Represses Tyrosine Hydroxylase Expression via SIRT1 in Human Neural Stem Cells

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Kim, Tae Eun ^a   Seo, Ji Sun ^a   Yang, Jae Won ^a   Kim, Min Woong ^a   Kausar, Rukhsana ^a   Joe, Eunhye ^a   Kim, Bo Yeon ^b   Lee, Myung Ae ^a  

^a Ajou University School of Medicine   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINAMIDE; NUCLEAR RECEPTOR RELATED FACTOR 1; SIRTUIN 1; TRICHOSTATIN A; TYROSINE 3 MONOOXYGENASE;

ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DOPAMINERGIC NERVE CELL; GENE CONTROL; GENE MUTATION; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOLECULAR MECHANICS; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; REGULATORY MECHANISM; TRANSCRIPTION REGULATION;

BASE SEQUENCE; BIOLOGICAL MARKERS; CELL LINE; CELL LINEAGE; HISTONE DEACETYLASES; HUMANS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; NEURAL STEM CELLS; NIACINAMIDE; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; REPRESSOR PROTEINS; SIRTUIN 1; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; TYROSINE 3-MONOOXYGENASE;

EID: 84881523773     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113335     Document Type: Erratum

References (54)

1. Freedman SB, Isner JM, (2001) Therapeutic angiogenesis for ischemic cardiovascular disease. J Mol Cell Cardiol 33: 379-393.
2. Olanow CW, Goetz CG, Kordower JH, Stoessl AJ, Sossi V, et al. (2003) A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 54: 403-414.
3. Andersson EK, Irvin DK, Ahlsiö J, Parmar M, (2006) Ngn2 and Nurr1 act in synergy to induce midbrain dopaminergic neurons from expanded neural stem and progenitor cells. Exp Cell Res 313: 1172-1180.
4. Hedlund E, Pruszak J, Lardaro T, Ludwig W, Viñuela A, et al. (2008) Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson's disease. Stem Cells 26: 1526-1536.
5. Kim TE, Lee HS, Lee YB, Hong SH, Lee YS, et al. (2003) Sonic hedgehog and FGF8 collaborate to induce dopaminergic phenotypes in the Nurr1-overexpressing neural stem cell. Biochem Biophys Res Commun 305: 1040-1048.
6. Chung CY, Seo H, Sonntag KC, Brooks A, Lin L, et al. (2005) Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection. Hum Mol Genet 14: 1709-1725.
7. Martinat C, Bacci JJ, Leete T, Kim J, Vanti WB, et al. (2006) Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype. Proc Natl Acad Sci U S A 103: 2874-2879.
8. Smidt MP, Burbach JP, (2007) How to make a mesodiencephalic dopaminergic neuron. Nat Rev Neurosci 8: 21-32.
9. Zetterström RH, Solomin L, Jansson L, Hoffer BJ, Olson L, et al. (1997) Dopamine neuron agenesis in Nurr1-deficient mice. Science 276: 248-250.
10. Saucedo-Cardenas O, Quintana-Hau JD, Le WD, Smidt MP, Cox JJ, et al. (1998) Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc Natl Acad Sci U S A 95: 4013-4018.
11. Castro DS, Hermanson E, Joseph B, Wallén A, Aarnisalo P, et al. (2001) Induction of cell cycle arrest and morphological differentiation by Nurr1 and retinoids in dopamine MN9D cells. J Biol Chem 276: 43277-43284.
12. Lee HS, Bae EJ, Yi SH, Shim JW, Jo AY, et al. (2010) Foxa2 and Nurr1 synergistically yield A9 nigral dopamine neurons exhibiting improved differentiation, function, and cell survival. Stem Cells 28: 501-512.
13. Chung S, Leung A, Han BS, Chang MY, Moon JI, et al. (2009) Wnt1-lmx1a forms a novel autoregulatory loop and controls midbrain dopaminergic differentiation synergistically with the SHH-FoxA2 pathway. Cell Stem Cell 5: 646-658.
14. Donaldson AE, Cai J, Yang M, Iacovitti L, (2009) Human amniotic fluid stem cells do not differentiate into dopamine neurons in vitro or after transplantation in vivo. Stem Cells Dev 18: 1003-1012.
15. Le WD, Xu P, Jankovic J, Jiang H, Appel SH, et al. (2003) Mutations in NR4A2 associated with familial Parkinson disease. Nat Genet 33: 85-89.
16. Kim TE, Park MJ, Choi EJ, Lee HS, Lee SH, et al. (2003) Cloning and cell type-specific regulation of the human tyrosine hydroxylase gene promoter. Biochem Biophys Res Commun 312: 1123-1131.
17. Jin H, Romano G, Marshall C, Donaldson AE, Suon S, et al. (2006) Tyrosine hydroxylase gene regulation in human neuronal progenitor cells does not depend on Nurr1 as in the murine and rat systems. J Cell Physiol 207: 49-57.
18. Sacchetti P, Mitchell TR, Granneman JG, Bannon MJ, (2001) Nurr1 enhances transcription of the human dopamine transporter gene through a novel mechanism. J Neurochem 76: 1565-1572.
19. Kim KS, Kim CH, Hwang DY, Seo H, Chung S, et al. (2003) Orphan nuclear receptor Nurr1 directly transactivates the promoter activity of the tyrosine hydroxylase gene in a cell-specific manner. J Neurochem 85: 622-634.
20. Sakurada K, Ohshima-Sakurada M, Palmer TD, Gage FH, (1999) Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain. Development 126: 4017-4026.
21. Kim JY, Koh HC, Lee JY, Chang MY, Kim YC, et al. (2003) Dopaminergic neuronal differentiation from rat embryonic neural precursors by Nurr1 overexpression. J Neurochem 85: 1443-1454.
22. Jacobs FM, van Erp S, van der Linden AJ, von Oerthel L, Burbach JP, et al. (2009) Pitx3 potentiates Nurr1 in dopamine neuron terminal differentiation through release of SMRT-mediated repression. Development 136: 531-540.
23. Romano G, Suon S, Jin H, Donaldson AE, Iacovitti L, (2005) Characterization of five evolutionary conserved regions of the human tyrosine hydroxylase (TH) promoter: implications for the engineering of a human TH minimal promoter assembled in a self-inactivating lentiviral vector system. J Cell Physiol 204: 666-677.
24. Kim SU, (2004) Human neural stem cells genetically modified for brain repair in neurological disorders. Neuropathology 24: 159-171.
25. Kim SU, Nakagawa E, Hatori K, Nagai A, Lee MA, et al. (2002) Production of immortalized human neural crest stem cells. Methods Mol Biol 198: 55-65.
26. Cho T, Bae JH, Choi HB, Kim SS, McLarnon JG, et al. (2002) Human neural stem cells: electrophysiological properties of voltage-gated ion channels. Neuroreport 13: 1447-1452.
27. Ryu JK, Choi HB, Hatori K, Heisel RL, Pelech SL, et al. (2003) Adenosine triphosphate induces proliferation of human neural stem cells: Role of calcium and p70 ribosomal protein S6 kinase. J Neurosci Res 72: 352-362.
28. Påhlman S, Odelstad L, Larsson E, Grotte G, Nilsson K, (1981) Phenotypic changes of human neuroblastoma cells in culture induced by 12-O-tetradecanoyl-phorbol-13-acetate. Int J Cancer 28: 583-589.
29. Tucholski J, Johnson GV, (2003) Tissue transglutaminase directly regulates adenylyl cyclase resulting in enhanced cAMP-response element-binding protein (CREB) activation. J Biol Chem 278: 26838-26843.
30. García-Yagüe ÁJ, Rada P, Rojo AI, Lastres-Becker I, Cuadrado A, (2013) Nuclear import and export signals control the subcellular localization of Nurr1 protein in response to oxidative stress. J Biol Chem 288: 5506-5517.
31. Kim SM, Yang JW, Park MJ, Lee JK, Kim SU, et al. (2006) Regulation of human tyrosine hydroxylase gene by neuron-restrictive silencer factor. Biochem Biophys Res Commun 346: 426-435.
32. Arredondo C, Orellana M, Vecchiola A, Pereira LA, Galdames L, et al. (2013) PIASγ enhanced SUMO-2 modification of Nurr1 activation-function-1 domain limits Nurr1 transcriptional synergy. PLoS One 8: e55035.
33. Perlmann T, Jansson L, (1995) A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. Genes Dev 9: 769-782.
34. Ichinose H, Ohye T, Suzuki T, Sumi-Ichinose C, Nomura T, et al. (1999) Molecular cloning of the human Nurr1 gene: characterization of the human gene and cDNAs. Gene 230: 233-239.
35. Castro DS, Arvidsson M, Bondesson Bolin M, Perlmann T, (1999) Activity of the Nurr1 carboxyl-terminal domain depends on cell type and integrity of the activation function 2. J Biol Chem 274: 37483-37490.
36. Michelhaugh SK, Vaitkevicius H, Wang J, Bouhamdan M, Krieg AR, et al. (2005) Dopamine neurons express multiple isoforms of the nuclear receptor nurr1 with diminished transcriptional activity. Neurochem 95: 1342-1350.
37. Mix KS, Attur MG, Al-Mussawir H, Abramson SB, Brinckerhoff CE, et al. (2007) Transcriptional repression of matrix metalloproteinase gene expression by the orphan nuclear receptor NURR1 in cartilage. J Biol Chem 282: 9492-504.
38. Senawong T, Peterson VJ, Avram D, Shepherd DM, Frye RA, et al. (2003) Involvement of the histone deacetylase SIRT1 in chicken ovalbumin upstream promoter transcription factor (COUP-TF)-interacting protein 2-mediated transcriptional repression. J Biol Chem 278: 43041-43050.
39. Gottlicher M, Minucci S, Zhu P, Kramer OH, Schimpf A, et al. (2001) Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 20: 6969-6978.
40. Zhang Y, Akinmade D, Hamburger AW, (2005) The ErbB3 binding protein Ebp1 interacts with Sin3A to repress E2F1 and AR-mediated transcription. Nucleic Acids Res 33: 6024-6033.
41. Chanda D, Xie YB, Choi HS, (2010) Transcriptional corepressor SHP recruits SIRT1 histone deacetylase to inhibit LRH-1 transactivation. Nucleic Acids Res 38: 4607-4619.
42. Hisahara S, Chiba S, Matsumoto H, Tanno M, Yagi H, et al. (2008) Histone deacetylase SIRT1 modulates neuronal differentiation by its nuclear translocation. Proc Natl Acad Sci U S A 105: 15599-15604.
43. Daniels DL, Weis WI, (2005) Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation. Nat Struct Mol Biol 12: 364-371.
44. Perissi V, Rosenfeld MG, (2005) Controlling nuclear receptors: the circular logic of cofactor cycles. Nat Rev Mol Cell Biol 6: 542-554.
45. Kitagawa H, Ray WJ, Glantschnig H, Nantermet PV, Yu Y, et al. (2007) A regulatory circuit mediating convergence between Nurr1 transcriptional regulation and Wnt signaling. Mol Cell Biol 27: 7486-7496.
46. Codina A, Benoit G, Gooch JT, Neuhaus D, Perlmann T, et al. (2004) Identification of a Novel Co-regulator Interaction Surface on the Ligand Binding Domain of Nurr1 Using NMR Footprinting. J Biol Chem 279: 53338-53345.
47. Galleguillos D, Vecchiola A, Fuentealba JA, Ojeda V, Alvarez K, et al. (2004) PIASgamma represses the transcriptional activation induced by the nuclear receptor Nurr1. J Biol Chem 279: 2005-2011.
48. Park KC, Song KH, Chung HK, Kim H, Kim DW, et al. (2005) CR6-interacting factor 1 interacts with orphan nuclear receptor Nur77 and inhibits its transactivation. Mol Endocrinol 19: 12-24.
49. Lammi J, Rajalin AM, Huppunen J, Aarnisalo P, (2007) Cross-talk between the NR3B and NR4A families of orphan nuclear receptors. Biochem Biophys Res Commun 359: 391-397.
50. Wu Y, Ghosh S, Nishi Y, Yanase T, Nawata H, et al. (2005) The orphan nuclear receptors NURR1 and NGFI-B modulate aromatase gene expression in ovarian granulosa cells: a possible mechanism for repression of aromatase expression upon luteinizing hormone surge. Endocrinology 146: 237-246.
51. Nagy L, Kao HY, Chakravarti D, Lin RJ, Hassig CA, et al. (1997) Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89: 373-380.
52. Zhu P, Baek SH, Bourk EM, Ohgi KA, Garcia-Bassets I, et al. (2006) Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway. Cell 124: 615-629.
53. Kim HS, Park JS, Hong SJ, Woo MS, Kim SY, et al. (2003) Regulation of the tyrosine hydroxylase gene promoter by histone deacetylase inhibitors. Biochem Biophys Res Commun 312: 950-957.
54. Dai Y, Ngo D, Forman LW, Qin DC, Jacob J, et al. (2007) Sirtuin 1 is required for antagonist-induced transcriptional repression of androgen-responsive genes by the androgen receptor. Mol Endocrinol 21: 1807-1821.